Scalper1 News
Some of the fattest annual profit margins come from drugmakers whose products are meant to make people healthier. Today’s Screen of the Day is Healthy Profit Margin and includes four highly rated drug stocks. Don’t miss out on Jazz Pharmaceuticals (JAZZ) and its annual profit margin of 54.4%. Its narcolepsy treatment, Xyrem, has rocketed to success and contributed to 65% of the drugmaker’s 2013 revenue. The company has an IBD Composite Rating of Scalper1 News
Scalper1 News